文献速递头颈外科

抗PD-1治疗后头颈部鳞状细胞癌的伤口并发症

Wound Complications in Head and Neck Squamous Cell Carcinomas After Anti-PD-1 Therapy.
PubMed 文献 · Laryngoscope · 2019-05-10

本文描述4例头颈部鳞状细胞癌患者在接受抗PD-1治疗并获得完全缓解后,出现需手术干预的伤口并发症。4例患者均成功接受手术治疗并保持无病状态。

要点

  • 抗PD-1治疗后完全缓解的头颈鳞癌患者可出现需手术干预的伤口并发症。
  • 4例患者分别出现下颌硬件暴露、颊部溃疡性病变伴下颌骨暴露、颅面骨放射性骨坏死及下颌骨暴露并骨折。
  • 所有患者均成功接受手术干预并保持无病状态。

核心结论

  • 抗PD-1治疗后完全缓解的头颈部鳞状细胞癌患者可出现需手术干预的伤口并发症。

研究设计与样本

  • 本文描述4例接受抗PD-1治疗后出现伤口并发症的头颈部鳞状细胞癌患者。

主要发现

  • 患者1为57岁女性,肿瘤显著消退后暴露部分下颌硬件。
  • 患者2为39岁男性,出现溃疡性颊部病变伴下颌骨暴露。
  • 患者3为66岁男性,出现颅面骨放射性骨坏死。
  • 患者4为71岁男性,出现下颌骨暴露并骨折。
  • 所有患者均成功接受手术干预并保持无病状态。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Immune checkpoint inhibitors have demonstrated activity in recurrent/metastatic head and neck squamous cell cancer, but less is known regarding their long-term sequelae. We describe four patients who, after complete responses to anti-PD-1 therapy, developed complications requiring surgical intervention. Patient 1 is a 57-year-old female whose marked tumor regression exposed some mandibular hardware. Patient 2 is a 39-year-old male who developed an ulcerated buccal lesion with exposed mandible. Patient 3 is a 66-year-old male with craniofacial osteoradionecrosis. Patient 4 is a 71-year-old male who developed an exposed and fractured mandible. All patients successfully underwent surgical intervention and remain disease free. Laryngoscope, 129:E428-E433, 2019.

来源:Laryngoscope,查看原文。版权归原作者所有。

引用

  1. Hwang V, Mendez E, Chow LQM, et al. Wound Complications in Head and Neck Squamous Cell Carcinomas After Anti-PD-1 Therapy. Laryngoscope. 2019. PMID: 31074843. doi:10.1002/lary.27902

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。